Martínez-Soto Juan Manuel, Candia-Plata Maria Del Carmen, López-Soto Luis Fernando, Soto-Guzmán Jesús Adriana, Camacho-Villa Alma Yolanda, Álvarez-Hernández Gerardo, Mata-Pineda Ana Lourdes, Galván-Moroyoqui José Manuel
Doctorado en Ciencias Químico Biológicas y de la Salud, Universidad de Sonora, Hermosillo, Sonora, Mexico.
Departamento de Medicina y Ciencias de la Salud, Universidad de Sonora, Hermosillo, Sonora, Mexico.
Heliyon. 2021 Apr 9;7(4):e06720. doi: 10.1016/j.heliyon.2021.e06720. eCollection 2021 Apr.
This pilot study aimed to determine if increased serum ferritin (SF) is associated with cardiovascular risk factors in patients with prediabetes.
Eighteen patients with prediabetes and 36 subjects without prediabetes (control), non-white Hispanic, non-indigenous origin, Mexican mestizo descent were included. Participants had no inflammation, or vascular complications. SF and metabolic markers were evaluated in both groups.
SF and oxidized low-density lipoprotein (oxLDL) were increased in prediabetes subjects. Moreover, in prediabetes and control groups as a whole, natural logarithm (ln)-SF correlated with oxLDL and ln-oxLDL/LDL after adjustment for sex, ln-age, ln-fasting plasma glucose (FPG), ln-body mass index, ln-triglyceride (TG), total cholesterol (TC), and high-density lipoproteins. Finally, ln-SF was an independent contributor to ln-oxLDL/LDL ratio in control and prediabetes subjects (β = 0.2915) after the introduction of potential confounders such as FPG, TC, TG, and hypertension.
The results of this study indicate that hyperferritinemia is associated with oxLDL, considered one of the main cardiovascular risk factors, which allows us to suggest that an increase in SF could contribute to the progression of prediabetes, prior to the appearance of diabetes. Further research is required to establish a causal relationship of iron disruption metabolism in oxLDL generation under prediabetes conditions.
本初步研究旨在确定血清铁蛋白(SF)升高是否与糖尿病前期患者的心血管危险因素相关。
纳入了18例糖尿病前期患者和36例无糖尿病前期的受试者(对照组),均为非西班牙裔白人、非原住民、墨西哥混血后裔。参与者无炎症或血管并发症。对两组患者的SF和代谢指标进行评估。
糖尿病前期患者的SF和氧化型低密度脂蛋白(oxLDL)升高。此外,在整个糖尿病前期和对照组中,经性别、自然对数(ln)年龄、ln空腹血糖(FPG)、ln体重指数、ln甘油三酯(TG)、总胆固醇(TC)和高密度脂蛋白校正后,ln-SF与oxLDL以及ln-oxLDL/LDL相关。最后,在引入FPG、TC、TG和高血压等潜在混杂因素后,ln-SF是对照组和糖尿病前期受试者ln-oxLDL/LDL比值的独立影响因素(β = 0.2915)。
本研究结果表明,高铁蛋白血症与oxLDL相关,oxLDL被认为是主要的心血管危险因素之一,这使我们认为SF升高可能在糖尿病出现之前就促进了糖尿病前期的进展。需要进一步研究以确定糖尿病前期条件下铁代谢紊乱在oxLDL生成中的因果关系。